Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
about
New pieces to an old puzzle: identifying the warfarin-binding site that prevents clotting.Genetic variation in human drug-related genes.Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.VKORC1 inhibitors binds VKORC1 dimerMissense mutation of VKORC1 leads to medial arterial calcification in rats
P2860
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@en
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@nl
type
label
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@en
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@nl
prefLabel
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@en
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@nl
P2093
P2860
P356
P1476
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
@en
P2093
Johannes Oldenburg
Katrin J Czogalla
Kerstin Liphardt
Klara Höning
Matthias Watzka
P2860
P2888
P356
10.1038/NSMB.3338
P577
2016-12-12T00:00:00Z